Close Menu

This article has been updated with additional information from Roche's earnings call.

NEW YORK (GenomeWeb) – Roche today reported an 8 percent year-over-year increase in revenues for its Diagnostics division for the first half of 2018, driven primarily by demand for immunodiagnostic solutions, which are part of the Centralized and Point of Care Solutions business segment.

For the first half of the year, the Roche Group reported CHF 28.11 billion ($28.34 billion) in total sales, up 7 percent from CHF 26.34 billion during the first half of 2017.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.